MEDICINAL AGENT POSSESSING PROTECTIVE EFFECT WITH RESPECT TO OXIDATIVE-TOXIC AND CARDIOTOXIC COMPOUNDS MAINLY Russian patent published in 2006 - IPC A61K31/55 A61P9/00 

Abstract RU 2268727 C2

FIELD: organic chemistry, medicine, cardiology, chemical-pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to using compounds of the formula (I) used in preparing pharmaceutical compositions designated for prophylaxis and/or treatment of disorders of cardiac activity induced by cardiotoxic doses of medicinal agents possessing the cytostatic effect of antibiotics or chemical compounds preferably. Compounds of the formula (I) possess high activity in treatment of disturbances of cardiac activity and high bioavailability.

EFFECT: valuable medicinal properties of compounds.

12 cl, 2 tbl, 3 ex

Similar patents RU2268727C2

Title Year Author Number
MEDICINAL AGENT FOR HYPERTENSION TREATMENT 2000
  • Uilkinz Martin R.
  • Tormehlen Dirk
  • Val'Dek Kharal'D
RU2270679C2
DERIVATIVES OF BENZAZEPINON-N-ACETIC ACID SUBSTITUTED WITH PHOSPHONIC ACID, METHOD FOR THEIR PREPARING AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS 1998
  • Val'Dek Kharal'D
  • Majl' Jorg
  • Tormelen Dirk
  • Vurl' Mikhel'
RU2211219C2
BENZAZEPIN, BENZOXAZEPIN OR BENZOTHIAZEPIN-N-ACETIC ACID, METHOD OF PREPARATION THEREOF, AND DRUG CONTAINED THEREIN 1996
  • Kharal'D Valdek
  • Dagmar Khelt'E
  • Jozef Messinger
  • Jokhen Antel'
  • Mikhel' Vurl
  • Dirk Tormelen
RU2159768C2
PHARMACEUTICAL COMPOSITIONS, INCLUDING NEP INHIBITORS, INHIBITORS OF SYSTEM PRODUCING ENDOGENIC ENDOTHELIUM AND DIURETICS 2006
  • Vitte Klaus
  • Tsigler Diter
  • Shtraub Mattias
  • Fisher Ivan
RU2409366C2
PHARMACEUTICAL COMPOSITIONS CONTAINING NEP-INHIBITORS, INHIBITORS OF ENDOGENOUS ENDOTHELIN-PRODUCING SYSTEM AND AT-RECEPTOR ANTAGONISTS 2005
  • Tsigler Diter
  • Vitte Klaus
  • Shtraub Mattias
  • Fisher Ivan
  • Tormehlen Dirk
  • Khel'T'E Dagmar
RU2384346C2
SOLID BENZAZEPIN COMPOUND SALTS AND THEIR USE IN PREPARATION OF PHARMACEUTICAL COMPOUNDS 2003
  • Van Der Ehrden Joris A.
  • De Jong Paulus P. G.
  • Van Der Mej Paulus F. K.
RU2303041C2
PHARMACEUTICAL COMPOSITIONS INCLUDING NEP (NEUTRAL ENDOPEPTIDASE) INHIBITORS, INHIBITORS OF ENDOGENOUS ENDOTHELIN-PRODUCING SYSTEM AND HMG (HYDROXYMETHYLGLUTARYL) CoA REDUCTASE INHIBITORS 2005
  • Vitte Klaus
  • Tsigler Diter
  • Shtraub Mattias
  • Kopman Paulus-Antonius-Remigius
RU2410118C2
INHIBITORS OF NEUTRAL ENDOPEPTIDASE (NEP) HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS 2005
  • Veske Mikhel'
  • Turski Lekhoslav A.
  • Ikonomidou Khrissanti
  • Tsigler Diter
RU2362563C2
ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION 2003
  • Gorissen Khenrikus R. M.
RU2314811C2
NEUTRAL ENDOPEPTIDASE (NEP) AND SOLUBLE HUMAN ENDOPEPTIDASE (SHE) INHIBITORS FOR PREVENTION AND TREATMENT OF EYE DISEASES 2019
  • Turski Kristofer
RU2758771C1

RU 2 268 727 C2

Authors

Rozha Zhuzhanna

Papp Julius D.

Tormehlen Dirk

Dates

2006-01-27Published

2000-07-10Filed